×
ArticlesCompany Highlights
March 2, 2022

Second research publication in collaboration with ICE Pharma and Ferrier Research Institute

Synthesis of 12β-methyl-18-nor-avicholic acid analogues as potential TGR5 agonists In the quest for new modulators of the Farnesoid-X (FXR) and Takeda G-protein-coupled (TGR5) receptors, bile acids are a popular...

ABCCompany Highlights
December 16, 2021

ICE Pharma acquires ABC Farmaceutici S.p.A.

We are pleased to announce that on December 15th ICE Pharma completed the acquisition of ABC Farmaceutici S.p.A. (“ABC”). ABC is a pharmaceutical company based in Ivrea, Italy. Founded...

ArticlesCompany Highlights
September 14, 2021

First research publication in collaboration with ICE Pharma and Ferrier Research Institute

Synthesis of 12β-Methyl-18-nor-bile Acids Decoupling the roles of the farnesoid X nuclear receptor and Takeda G-protein-coupled bile acid receptor 5 is essential for the development of novel bile acid...

Company HighlightsInsights
June 3, 2021

ICE Pharma Cogenerator Project in Basaluzzo manufacturing site

In May 2019 the cogenerator project was ended and realized. Project was supported by POS FESR PIEMONTE 2014-2020. The principal goals of the project were: All these objects agree...